On May 4, 2021, the President signed into law H.R. 2630, also known as the "Extending Temporary Emergency Scheduling of Fentanyl Analogues Act." This legislation extends the temporary scheduling order that designates certain fentanyl-related substances as Schedule I drugs, which are subject to the strictest controls. The extension lasts until October 22, 2021.